Abstract 1383: A next-generation PI3Kδ/γ inhibitor, ZX-101A inhibiting solid tumor growth by enhancing anti-tumor immunity von Hao, Xiaolin, Peng, Zhiyuan, Guo, Kun, Li, Ying-Ying, Kong, Deming, Yang, Jinfu, Qin, Xiaoli (Shelley)

Volltext

Abstract CT202: A phase 1/2a, dose-escalation and dose-expansion study of ZX-101A in patients with relapsed/resistant or refractory advanced hematologic malignancies von Qin, Xiaoli (Shelley), Bautista, Edgar, Teitelbaum, April, Hao, Xiaolin, Yang, Jinfu

Volltext

Abstract 1384: Selective PI3Kγ inhibitor ZX-4081 reprograms the tumor microenvironment to facilitate anti-cancer immunity von Li, Ying-Ying, Guo, Kun, Peng, Zhiyuan, Kong, Deming, Hao, Xiaolin, Yang, Jinfu, Qin, Xiaoli (Shelley)

Volltext

Abstract 1275: Potent ENPP1 inhibitors activating STING pathway in tumor microenvironment von Peng, Zhiyuan, Guo, Kun, Li, Ying-Ying, Kong, Deming, Yang, Jinfu, (Shelley) Qin, Xiaoli, Hao, Xiaolin

Volltext

Abstract 5486: ENPP1 inhibitor ZX-8177 enhances anti-tumor activity of conventional therapies by modulating tumor microenvironment von Li, Ying-ying, Peng, Zhiyuan, Sun, Shuaijun, Guo, Kun, Kong, Deming, Li, Xiaomin, Xie, Yuning, Shui, Siyu, Wang, Yin, Yang, Jinfu, Hao, Xiaolin Alan, Qin, Xiaoli (Shelley)

Volltext